NEW YORK (GenomeWeb News) – Roche today said that Molecular Diagnostic sales rose 4 percent year over year at constant exchange rates, while Diagnostic Division revenues were up also 4 percent in the second quarter.

Molecular Diagnostics increased to to CHF411 million ($439.9 million) from CHF395 million as Diagnostic Division revenues increased to CHF2.71 billion from CHF2.61 billion

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.